Priority Date: 14.12.10 (US 20100422954P)

ADENOVIRUS SEROTYPE 26 AND SEROTYPE 35 FILOVIRUS VACCINES

  • Application ID: EP11849865
  • Status: The patent has been granted

Applicant

Company dna crucell holland bv
active in Legal Services

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
active in Legal Services
no operation time available
1 office
Technology Company
no operation time available
1 office
active in Legal Services

Specialization

This EP application has the IPC class A61, C07, and C12. Janssen Vaccines & Prevention B.V. and Crucell Holland B.V. are specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 131 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.12.2010 - Priority Date (US 20100422954P)
  • 21.06.2012 - Publication A1 (WO2012082918)
  • 30.10.2013 - Publication A1 (EP2655604)
  • 09.05.2018 - Publication B1 (EP2655604)